Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23324841)

1.

Females with subclavian vein thrombosis may have an increased risk of hypercoagulability.

Likes K, Rochlin D, Nazarian SM, Streiff MB, Freischlag JA.

JAMA Surg. 2013 Jan;148(1):44-9. doi: 10.1001/jamasurgery.2013.406.

PMID:
23324841
2.

Preoperative thrombolysis and venoplasty affords no benefit in patency following first rib resection and scalenectomy for subacute and chronic subclavian vein thrombosis.

Guzzo JL, Chang K, Demos J, Black JH, Freischlag JA.

J Vasc Surg. 2010 Sep;52(3):658-62; discussion 662-3. doi: 10.1016/j.jvs.2010.04.050.

3.

Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.

Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviú MJ, Gennari L, Lazzari MA.

Am J Hematol. 2004 Aug;76(4):330-7.

PMID:
15282664
4.

Saphenous vein thrombophlebitis (SVT): a deceptively benign disease.

Hanson JN, Ascher E, DePippo P, Lorensen E, Scheinman M, Yorkovich W, Hingorani A.

J Vasc Surg. 1998 Apr;27(4):677-80.

PMID:
9576081
5.

Subclavian vein thrombosis: outcome analysis based on etiology and modality of treatment.

Beygui RE, Olcott C 4th, Dalman RL.

Ann Vasc Surg. 1997 May;11(3):247-55.

PMID:
9140599
6.

Thrombophilia testing in patients with venous thrombosis.

Caprini JA, Goldshteyn S, Glase CJ, Hathaway K.

Eur J Vasc Endovasc Surg. 2005 Nov;30(5):550-5. Epub 2005 Aug 1.

7.

Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis.

Friedman GS, Meier-Kriesche HU, Kaplan B, Mathis AS, Bonomini L, Shah N, DeFranco P, Jacobs M, Mulgaonkar S, Geffner S, Lyman N, Paraan C, Walsh C, Belizaire W, Tshibaka M.

Transplantation. 2001 Sep 27;72(6):1073-8.

PMID:
11579303
8.

Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.

Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.

Circulation. 2004 Aug 3;110(5):566-70. Epub 2004 Jul 19.

9.

Factors associated with the development of superficial vein thrombosis in patients with varicose veins.

Karathanos C, Exarchou M, Tsezou A, Kyriakou D, Wittens C, Giannoukas A.

Thromb Res. 2013 Jul;132(1):47-50. doi: 10.1016/j.thromres.2013.05.017. Epub 2013 Jun 12.

PMID:
23768449
10.

First rib resection and scalenectomy for chronically occluded subclavian veins: what does it really do?

de León R, Chang DC, Busse C, Call D, Freischlag JA.

Ann Vasc Surg. 2008 May-Jun;22(3):395-401. doi: 10.1016/j.avsg.2007.12.020.

PMID:
18466817
11.

Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.

Lahey JM, Tunç M, Kearney J, Modlinski B, Koo H, Johnson RN, Tanaka S.

Ophthalmology. 2002 Jan;109(1):126-31.

PMID:
11772591
12.

Hypercoagulable states in primary upper-extremity deep vein thrombosis.

Héron E, Lozinguez O, Alhenc-Gelas M, Emmerich J, Fiessinger JN.

Arch Intern Med. 2000 Feb 14;160(3):382-6.

PMID:
10668841
13.

Hypercoagulability states in upper-extremity deep venous thrombosis.

Leebeek FW, Stadhouders NA, van Stein D, Gómez-García EB, Kappers-Klunne MC.

Am J Hematol. 2001 May;67(1):15-9.

PMID:
11279652
14.

Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain.

Fichera A, Cicchiello LA, Mendelson DS, Greenstein AJ, Heimann TM.

Dis Colon Rectum. 2003 May;46(5):643-8.

PMID:
12792441
15.

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis.

Auerbach AD, Sanders GD, Hambleton J.

Am J Med. 2004 Jun 15;116(12):816-28. Review.

PMID:
15178497
16.

[Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism].

Tokuyama K, Kiuchi K, Nejima J, Takayama M, Takano T, Hayakawa H.

J Cardiol. 1998 Oct;32(4):263-8. Japanese.

PMID:
9833233
17.

Routine venography following transaxillary first rib resection and scalenectomy (FRRS) for chronic subclavian vein thrombosis ensures excellent outcomes and vein patency.

Chang KZ, Likes K, Demos J, Black JH 3rd, Freischlag JA.

Vasc Endovascular Surg. 2012 Jan;46(1):15-20. doi: 10.1177/1538574411423982. Epub 2011 Dec 8.

PMID:
22156150
18.

Hepatocavopathy and isolated splenic vein thrombosis due to hypercoagulability state.

Akarsu M, Seçil M, Yener S, Topalak O.

Turk J Gastroenterol. 2005 Sep;16(3):153-5.

PMID:
16245227
19.

Long-term outcome of infrainguinal bypass grafting in patients with serologically proven hypercoagulability.

Curi MA, Skelly CL, Baldwin ZK, Woo DH, Baron JM, Desai TR, Katz D, McKinsey JF, Bassiouny HS, Gewertz BL, Schwartz LB.

J Vasc Surg. 2003 Feb;37(2):301-6.

PMID:
12563199
20.

Familial thrombophilia and retinal vein occlusion.

Backhouse O, Parapia L, Mahomed I, Lee D.

Eye (Lond). 2000 Feb;14 ( Pt 1):13-7.

PMID:
10755093
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk